[
    [
        {
            "time": "2021-04-21",
            "original_text": "智飞生物（300122）：代理产品和自主产品放量推动Q1业绩高增，新冠疫苗Q2有望大幅贡献业绩",
            "features": {
                "keywords": [
                    "智飞生物",
                    "代理产品",
                    "自主产品",
                    "Q1业绩高增",
                    "新冠疫苗",
                    "Q2贡献业绩"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物（300122）：代理产品和自主产品放量推动Q1业绩高增，新冠疫苗Q2有望大幅贡献业绩",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "一季度高仓位运作，银华基金李晓星4000字长文谈投资逻辑",
            "features": {
                "keywords": [
                    "一季度高仓位",
                    "银华基金",
                    "李晓星",
                    "投资逻辑"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "一季度高仓位运作，银华基金李晓星4000字长文谈投资逻辑",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "9成盈利、54家业绩翻番：基金增持，医药股掀涨停潮",
            "features": {
                "keywords": [
                    "9成盈利",
                    "54家业绩翻番",
                    "基金增持",
                    "医药股",
                    "涨停潮"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "9成盈利、54家业绩翻番：基金增持，医药股掀涨停潮",
                "Correlation": 7,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "粤开医药研究|网售处方药全面放开，第五批带量采购箭在弦上",
            "features": {
                "keywords": [
                    "网售处方药",
                    "全面放开",
                    "第五批带量采购",
                    "医药研究"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "粤开医药研究|网售处方药全面放开，第五批带量采购箭在弦上",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "渤海证券-医药行业周报：药品与耗材国采推进，结合估值与业绩探寻机会【行业研究】",
            "features": {
                "keywords": [
                    "渤海证券",
                    "医药行业周报",
                    "药品与耗材国采",
                    "估值与业绩"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "渤海证券-医药行业周报：药品与耗材国采推进，结合估值与业绩探寻机会【行业研究】",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "国元证券-智飞生物年报&2021Q1季报点评：业绩实现高速增长，“自研+代理”两开花【公司研究】",
            "features": {
                "keywords": [
                    "国元证券",
                    "智飞生物",
                    "年报",
                    "季报点评",
                    "业绩高速增长",
                    "自研+代理"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国元证券-智飞生物年报&2021Q1季报点评：业绩实现高速增长，“自研+代理”两开花【公司研究】",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "八大券商主题策略：A股医药行业龙头名单精选 这些都是核心赛道！",
            "features": {
                "keywords": [
                    "八大券商",
                    "A股医药行业",
                    "龙头名单",
                    "核心赛道"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "八大券商主题策略：A股医药行业龙头名单精选 这些都是核心赛道！",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "平安证券-智飞生物：2020保持快速增长，2021等待新冠苗放量、微卡获批【公司研究】",
            "features": {
                "keywords": [
                    "平安证券",
                    "智飞生物",
                    "2020快速增长",
                    "2021新冠苗放量",
                    "微卡获批"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "平安证券-智飞生物：2020保持快速增长，2021等待新冠苗放量、微卡获批【公司研究】",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "【医药】药品耗材国采持续推进，医改稳态化下结合业绩寻机会――医药行业周报—―中性",
            "features": {
                "keywords": [
                    "药品耗材国采",
                    "医改稳态化",
                    "业绩寻机会",
                    "医药行业周报"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药】药品耗材国采持续推进，医改稳态化下结合业绩寻机会――医药行业周报—―中性",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "东吴证券-智飞生物：业绩超市场预期，新冠疫苗业绩兑现再即【公司研究】",
            "features": {
                "keywords": [
                    "东吴证券",
                    "智飞生物",
                    "业绩超预期",
                    "新冠疫苗",
                    "业绩兑现"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "东吴证券-智飞生物：业绩超市场预期，新冠疫苗业绩兑现再即【公司研究】",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "疫苗板块持续走高，康华生物大涨8%",
            "features": {
                "keywords": [
                    "疫苗板块",
                    "康华生物",
                    "大涨8%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫苗板块持续走高，康华生物大涨8%",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "看好医药股明星基金一季度增持",
            "features": {
                "keywords": [
                    "医药股",
                    "明星基金",
                    "一季度增持"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "看好医药股明星基金一季度增持",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "中原晨会0421】医药行业月报、市场分析、亿纬锂能年报点评、农林牧渔行业周报、汽车行业中报、光线传媒年报点评",
            "features": {
                "keywords": [
                    "中原晨会",
                    "医药行业月报",
                    "市场分析",
                    "亿纬锂能年报",
                    "农林牧渔行业周报",
                    "汽车行业中报",
                    "光线传媒年报"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "中原晨会0421】医药行业月报、市场分析、亿纬锂能年报点评、农林牧渔行业周报、汽车行业中报、光线传媒年报点评",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "智飞生物2020年年报及2021年一季报点评：业绩超市场预期，新冠疫苗业绩兑现再即",
            "features": {
                "keywords": [
                    "智飞生物",
                    "2020年报",
                    "2021一季报",
                    "业绩超预期",
                    "新冠疫苗",
                    "业绩兑现"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物2020年年报及2021年一季报点评：业绩超市场预期，新冠疫苗业绩兑现再即",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]